|
||
|
Hi {{ personalization_token('contact.firstname', 'CP Subscriber') }}, Plasmid DNA is foundational to some of the most promising therapies in development right now, including cell and gene therapies, viral vectors, mRNA, and DNA vaccines. But manufacturing it consistently, at scale, and at the quality the field demands is where a lot of programs run into trouble. Join me on Thursday, August 27 at 11:00 AM ET for: Optimizing Plasmid Manufacturing for Cell and Gene Therapy. We'll cover plasmid design, process development, purification, and how an integrated CMC-to-GMP approach can reduce risk and keep your program on track from preclinical through commercialization. Even if you can't attend live, the webinar will be available to watch on-demand at your convenience.
|
